Redox Regulation of the Human Xenobiotic Metabolizing Enzyme Arylamine N-Acetyltransferase 1 (NAT1)

This publication has 57 references indexed in Scilit:

• In silico sequence analysis of arylamine N-acetyltransferases: evidence for an absence of lateral gene transfer from bacteria to vertebrates and first description of paralogs in bacteria
  Biochemical and Biophysical Research Communications, 2002
• Arylamine N-acetyltransferases and Drug Response
  Pharmacogenomics, 2002
• NAT— from bugs to brains An overview of the 2nd International Workshop on the arylamine N-acetyltransferases
  The Pharmacogenomics Journal, 2002
• The pharmacogenetics of NAT: structural aspects
  Pharmacogenomics, 2002
• Pharmacogenetics of the arylamine N-acetyltransferases
  The Pharmacogenomics Journal, 2002
• Identification and Functional Characterization of Arylamine N -Acetyltransferases in Eubacteria: Evidence for Highly Selective Acetylation of 5-Aminosalicylic Acid
  Journal of Bacteriology, 2001
• Arylamine N-acetyltransferases – of mice, men and microorganisms
  Trends in Pharmacological Sciences, 2001
• N-Acetyltransferase genetics and their role in predisposition to aromatic and heterocyclic amine-induced carcinogenesis
  Toxicology Letters, 2000
• Guest Editorial
  Biological Chemistry, 1998
• Mapping AAC1, AAC2 and AACP, the genes for arylamine N-acetyltransferases, carcinogen metabolising enzymes on human chromosome 8p22, a region frequently deleted in tumours
  Cytogenetic and Genome Research, 1997